Coxsackievirus B3 (CVB3) is a principal viral cause of acute myocarditis in humans and has been implicated in the pathogenesis of dilated cardiomyopathy. It has been demonstrated elsewhere that, for 2 wild-type CVB3 strains, the primary molecular determinant of cardiovirulence phenotype localizes to the 5 nontranslated region (5 NTR). Here in this study, through construction of CVB3 chimeras, the predicted stem loop (SL) II within the 5 NTR has been identified as a primary viral determinant of cardiovirulence. Replication assays in cardiac-derived murine fibroblasts revealed that only cardiovirulent strains grow robustly at 37ЊC, whereas all virus strains replicate efficiently in HeLa cells. Computational analyses of RNA secondary structure suggest that the predicted SLII of the noncardiovirulent isolate differs significantly from that of myocarditic strains. These results indicate that, for clinical CVB3 isolates, the major determinant of cardiovirulence localizes to the predicted SLII. The identity of this higher-order RNA structure may be essential for productive infection of cardiac cells.
have been shown to interact with specific host and viral proteins that are required for translation and/or replication of the viral genome (reviewed in [19] ). Translation of the picornavirus open-reading frame occurs in a cap-independent manner that involves internal binding of the ribosomal initiation complex to an element within the 5 NTR, termed the "internal ribosomal entry site" [16] . For the poliovirus Sabin vaccine strains, perturbations in internal ribosomal entry site function have been implicated as the basis for their neuroattenuated phenotypes [20] [21] [22] [23] . These strains have been demonstrated to exhibit significantly diminished growth capacity on neuroblastoma cell lines, compared with their neurovirulent parental viruses [24, 25] .
Among the nonpolio enteroviruses, examination of the molecular determinants of pathogenesis has relied on the generation of phenotypically distinct virus strains by cell culture techniques, passage in animal systems, or immunologic variability [26] [27] [28] . Although these approaches have yielded information regarding viral determinants of virulence phenotype, difficulties arise when general information derived from the characterization of these laboratory-derived strains is applied to naturally occurring or so-called "wild-type" isolates. Determinants of cardiovirulence phenotype have been localized to the 5 NTR [29, 30] or capsid [27] by use of laboratory strains of CVB3. Although these reports have been beneficial in providing insight into the possible molecular determinants of CVB3 cardiovirulence phenotype, they may not be applicable to those of naturally occurring strains. Determinants identified in several other studies do not exist [31] or are not correlated with the known cardiovirulence phenotypes of naturally occurring clinical CVB3 isolates [32] .
In a previous report, we demonstrated that the primary molecular determinants of inflammatory heart disease, for naturally occurring clinical CVB3 strains, localized to the 5 NTR [32] . Homologous exchange of the capsid-coding region of a murine cardiovirulent clone of CVB3 (CVB3/20) with sequences from murine cardiovirulent and noncardiovirulent clinical isolates (CVB3/AS and CVB3/CO, respectively) failed to alter the CVB3/ 20 cardiovirulent phenotype. In a similar way, the exchange of the CVB3/20 5 NTR with that of CVB3/AS failed to modify the background cardiovirulent phenotype. However, substitution of the CVB3/20 5 NTR with that of CVB3/CO resulted in a noncardiovirulent chimera, a finding that identifies the 5 NTR as a major cardiovirulence determinant.
To identify regions for the construction of intra-5 NTR recombinants, and thereby further map the natural determinants of cardiovirulence phenotype, we analyzed the sequence diversity within the 5 NTRs of these phenotypically and genotypically distinct naturally occurring CVB3 strains. We found that upstream 5 NTR sequences comprising the putative SLII significantly influence CVB3-induced inflammatory heart disease and productive viral infection, in murine cardiac-derived cells.
MATERIALS AND METHODS

Cells and viruses.
HeLa cells (American Type Culture Collection) and primary murine fetal heart fibroblasts (MFHF) [30] were maintained as monolayers in MEM supplemented with 10% (vol/vol) fetal calf serum, 2 mM l-glutamine, 25.5 mM sodium bicarbonate, and 50 mg/mL gentamicin. The cardiovirulence phenotypes of CVB3/AS, CVB3/CO, and CVB3(5 NTR)ECV12 have been characterized elsewhere [31] [32] [33] [34] [35] . The complete sequence and characterization of the full-length infectious cDNA clone of CVB3/20 has been described elsewhere [36] . Aliquots of low-passage virus stocks were obtained by inoculation of nearly confluent HeLa cell monolayers, at an MOI of 0.5-1 TCID 50 /cell, and were stored at Ϫ80ЊC.
Construction and generation of intratypic 5 NTR CVB3 chimeras. The following primers were used to generate intratypic chimeric 5 NTR amplicons, by overlap polymerase chain reaction (PCR) [37] : T1 (5 -TCACTATAGGTTAAAACAGC-3 ), JRp64 [36] and downstream sequences from CVB3/CO, contained in CVB3/CO5 P1/20 [32] , respectively. The resultant PCR products were fused by overlap PCR, by use of primers T1 and JRpATG. The remaining SLII chimeras were generated by use of a similar strategy. The AS-SLII/CO/20 5 NTR amplicon was generated by fusion of CVB3/ AS upstream sequences (T1 to AS/180r) from CVB3/AS5 P1/ 20 [32] with CVB3/CO downstream sequences (CO/180f to JRpATG). Fusion of CVB3/CO upstream sequences (JRp64 to CO/180r) with CVB3/20 downstream sequences (20/180f to JRpATG) yielded CO-SLII/20. Fusion of CVB3/CO upstream sequences (JRp64 to CO/180r) with CVB3/AS downstream sequences (AS/180f to JRpATG) yielded CO-SLII/AS/20. Construction of the CVB3(SLII)ECV12 chimera has been described elsewhere [33] .
Overlap PCR products were blunt end-cloned into the Srf I site of pCRscript (Stratagene) and were sequenced for confirmation. Next, the cloned chimeric 5 NTRs were digested with Kpn I (nt 69) and Sac I (nt 751), and the resulting fragment was purified. To obtain full-length cDNA clones, we inserted 2 ϫ 10 dard infectivity assay, as described elsewhere [32] .
Sequencing of reverse transcription (RT)-PCR products and cloned amplicons. Direct sequencing of RT-PCR products and clones was performed by use of the ThermoSequenase (Amersham) terminator cycle sequencing protocol, as reported elsewhere [32] . Sequence analysis of the 5 NTRs of CVB3/20, CVB3/AS, and CVB3/CO was performed by the MacVector sequence analysis program (version 6.0; Oxford Molecular Group) and the Wisconsin Sequence Analysis Package (version 10.0; Genetics Computer Group).
Determination of cardiac virus titers and cardiovirulence phenotype in mice. Groups of 5 juvenile (21-25 days old) C3H/HeJ male mice (Jackson Laboratory) were inoculated intraperitoneally with TCID 50 of each virus in 0.1 mL of 5 5 ϫ 10 unsupplemented MEM or were inoculated with media alone (negative control), as described elsewhere [32] . Groups of mice were maintained in separate microisolators in a ventilated containment facility. Mice were sacrificed 10 days after inoculation, and hearts were excised and were examined for evidence of myocarditis. The myocarditis lesion score of each group was determined according to the following scale: 0, no myocarditis; 1, 1-10 lesions/section; 2, 11-20 lesions/section; 3, 21-40 lesions/section; and 4, widespread and confluent inflammation [27, 32] .
About one-quarter of each heart was homogenized and was used to determine cardiac virus titers. Virus concentration in homogenized heart tissue was titrated as described above and was expressed as log TCID 50 per gram of heart tissue.
Extraction and amplification of viral genomes from cardiac samples. From each group of inoculated mice, 2 homogenized cardiac samples were used for RT-PCR amplification of the viral genome and for direct sequencing of the 5 NTR. Total nucleic acid was extracted from 100 mL of each homogenized cardiac sample by use of guanidinium isothiocyanate (IsoQuick; ORCA Research), was precipitated, was washed in 70% ethanol, and was dried. High-fidelity RT-PCR was done as described above by use of the primer pairs JRp64/MD90, MD91/JRpATG, and JRp577/3 PUFF [38] . Detected amplicons were purified and were directly cycle sequenced, to verify the fidelity of the 5 NTR of the infecting genotype and, in some instances, partial capsid sequences.
Viral replication in cell culture. HeLa cell and MFHF monolayers of or cells, respectively, in duplicate 5 4 2 ϫ 10 5 ϫ 10 35-mm 2 plates (Corning) were washed once with PBS, were infected at an MOI of 10 TCID 50 /cell, in a volume of 500 mL, and were allowed to adsorb for 30 min at room temperature. Plates were then washed twice with PBS to remove unbound virus, were refed with 2 mL of supplemented MEM, and were incubated at either 37ЊC or 33.5ЊC with 5% CO 2 . At the appropriate intervals, plates were removed from the incubator, were frozen thrice, and were thawed. One milliliter of culture was transferred to a microcentrifuge tube and was clarified by centrifugation. Virus titer was determined as described above.
Computer analysis of secondary RNA structures. The RNA secondary structures of the sequences spanning nt 88-181 of CVB3/20 and CVB3/AS and nt 88-186 of CVB3/CO were predicted by the Wisconsin Sequence Analysis Package (version 10.0; Genetics Computer Group), m-fold program (version 2.3), and the online m-fold server at http://www.bioinfo.rpi .edu/applications/mfold/old/rna. The default parameters (37ЊC, 1 M NaCl, no divalent ions, and 5% suboptimality) and the energy parameters given by Mathews et al. [39] were used for the predictions.
RESULTS
Sublocalization of the cardiovirulence determinant within the CVB3 5 NTR. Alignment of CVB3/AS, CVB3/CO, and CVB3/20 5 NTR sequences revealed significant nucleotide diversity among the 3 CVB3 strains within upstream and downstream 5 NTR regions (nt 88-181 and nt 452-742, relative to CVB3/20, respectively). Within the upstream region, the noncardiovirulent CVB3/CO strain was 62% and 63% identical with the myocarditic CVB3/AS and CVB3/20 strains, respectively, whereas CVB3/AS and CVB3/20 were 85% identical. In addition, within this region of the CVB3/CO 5 NTR, 5 additional nucleotides were present, compared with the other 2 strains (figure 1). Within the region spanning nt 452-742, CVB3/20 and CVB3/ AS were 90% identical. In contrast, CVB3/CO was 80% and 82% identical with CVB3/AS and CVB3/20, respectively, within this region. Analysis of the intervening sequences of the 5 NTR (nt 182-451) revealed that all 3 strains were 92%-97% identical.
On the basis of the 5 NTR sequence analysis, a panel of intra-5 NTR CVB3 chimeras (figure 2) was generated to de- Schematic representation of parental and recombinant coxsackievirus B3 (CVB3) 5 nontranslated region (NTR), myocarditis lesion score, and cardiac virus titers. Linear representation of predicted secondary structure within 5 NTR, representing intra-5 NTR chimeras constructed, is shown above diagrams. Myocarditis lesion scoring was performed as described in Materials and Methods. Cardiac viral titers are given as log TCID 50 per gram of heart tissue. *, Four of 5 mice inoculated with CO-SLII/20 displayed no evidence of myocarditis. **, Viable virus was recovered from 1 of 5 mice inoculated with CO-SLII/20, and cardiac virus titer from this mouse was 3.9 log TCID 50 /g of heart tissue. AUG, true initiation codon; ND, no virus detected.
termine whether the identified regions of nucleotide diversity contained the primary determinant of cardiovirulence. Each chimera constructed retained the CVB3/20 "cloverleaf" structure (SLI). The downstream nt 452-742 from CVB3/AS were used to replace the homologous region of a noncardiovirulent chimera, CVB3/CO5 P1/20 [32] , containing the CVB3/CO 5 NTR and capsid coding sequences in the CVB3/20 background (figure 2). The resultant virus, AS(B-ATG)/CO/20, retained a noncardiovirulent phenotype when juvenile male C3H/HeJ mice were inoculated with it (figure 3E). The lack of observed change in virulence phenotype of the chimera excluded the downstream region of diversity as the site of the cardiovirulence determinant.
The contribution of upstream 5 NTR sequences to cardiovirulence phenotype was explored by homologous exchange of nt 88-181 (numeration relative to CVB3/20) from the cardiovirulent CVB3/20 and CVB3/AS5 P1/20 [32] viruses, with corresponding sequences (nt 88-186) from the noncardiovirulent CVB3/CO isolate, yielding CO-SLII/20 and CO-SLII/AS/ 20, respectively (figure 2). For CO-SLII/AS/20, the cardiovirulent phenotype was found to be abrogated in all inoculated mice (figure 3F). No virus was detected in the hearts of these mice by either infectious assay or RT-PCR (data not shown). Similar to this finding, inoculation with CO-SLII/20 resulted in near abrogation of the parental cardiovirulent phenotype ( figure 3G ). Only 1 of 5 mice inoculated with CO-SLII/20 exhibited myocardial inflammatory disease, and, in this mouse, disease was mild. A low titer (3.9 log TCID 50 of virus/g of heart tissue) was recovered from the heart of this mouse (figure 2). As expected, RT-PCR amplification of this homogenized heart tissue detected the presence of viral genome. Direct sequencing of the 5 NTR revealed that no mutations had occurred that could explain the low-level cardiovirulence. No viable virus was recovered from the homogenized myocardium of the remaining mice that had been inoculated with CO-SLII/20(figure 2), nor was viral genome detected in these mice by RT-PCR.
To confirm that nt 88-181 contained the major determinant of cardiovirulence, 2 additional intratypic CVB3 chimeras were generated. As reported elsewhere, the noncardiovirulent chimera CVB3/CO5 P1/20 was consistently unable to induce acute myocardial damage in a murine model [32] . Furthermore, no infectious virus could be recovered from the hearts of mice inoculated with this chimera. When nt 88-186 of CO5 P1/20 were replaced with homologous sequences from either CVB3/ 20 or CVB3/AS (yielding chimeras 20-SLII/CO/20 and AS-SLII/ CO/20, respectively), the noncardiovirulent phenotype converted to a cardiovirulent one ( figure 3H and 3I ). In addition, after inoculation of these chimeras, virus was recovered from the myocardia of all mice tested (figure 2). RT-PCR amplification and direct sequencing of 5 NTR nt 88-742 demonstrated that myocardium-derived viruses were identical to those of the inoculum. Taken as a whole, the phenotypic analyses of these chimeric viruses confirm that the identity of the predicted SLII is a cardiovirulence determinant.
CVB3 replication in cardiac-derived cells correlates with cardiovirulence phenotype. The growth characteristics of parental and intra-5 NTR recombinant CVB3 were examined in HeLa and primary MFHF cell cultures. Both attenuated and cardiovirulent viruses replicated efficiently and with similar growth kinetics in HeLa cells (figure 4). In contrast, only those strains found to induce inflammatory heart lesions in mice were capable of significant growth in MFHF at 37ЊC (figure 5A).
The noncardiovirulent CVB3 strains displayed a temperature-sensitive growth phenotype in MFHF. Whereas limited or no growth was observed at 37ЊC (figure 5B), the amyocarditic strains were found to replicate with efficiency similar to that of the cardiovirulent viruses, when incubated at 33.5ЊC ( figure  5C ). The growth kinetics of CVB3/20 were efficient at both temperatures (data not shown).
The attenuated phenotype of an intertypic enterovirus chimera can be reversed through SLII exchange. We have elsewhere reported on the characterization of an intertypic enterovirus chimera containing the echovirus 12 (Travis strain) 5 NTR within the background of the 0 strain of CVB3 [33] . This chimera, designated CVB3(5 NTR)ECV12 (figure 2), was found to be restricted for replication on 2 primary murine cell lines, MFHF and embryonic liver cells (BNL CL.2), but was found to replicate with efficiency similar to that of CVB3 on HeLa cells. In addition, the ECV12 5 NTR was found to be responsible for an attenuated cardiovirulence phenotype. Homologous exchange of nucleotides that constitute the putative ECV12 SLII with those of CVB3, an exchange that generated the virus CVB3(SLII)ECV12 (figure 2), relieved the growth restriction on MFHF and BNL CL.2 cells.
Given the effects of SLII exchanges between the CVB3 strains described above on cardiovirulence phenotype, we reasoned that CVB3(SLII)ECV12 might exhibit a myocarditic phenotype. Inoculation with ECV12(5 NTR)CVB3 resulted in no histological heart damage, a finding that confirms our observations elsewhere [33] (data not shown). In contrast, inoculation with CVB3(SLII)ECV12 resulted in inflammatory heart lesions, which are indicative of acute myocarditis ( figure 3J) . Thus, the nucleotides that constitute the CVB3/0 SLII, which are identical to those of CVB3/20, reversed the attenuated phenotype of ECV12(5 NTR)CVB3. This finding further supports the idea that, in naturally occurring isolates of CVB3, SLII is the major determinant of cardiovirulence phenotype. Predicted RNA secondary structure of 5 NTR nt 88-181 and 88-186. To assess the potential role that RNA secondary structure might play in determining CVB3 cardiovirulence phenotype, nt 88-181 of CVB3/AS and CVB3/20 and nt 88-186 of CVB3/CO, which include the putative SLI-II linker sequences and SLII, were analyzed by use of the m-fold algorithm.
Computational folding predicted a possible optimum structure for nt 88-181 of CVB3/AS and CVB3/20. Although the cardiovirulent CVB3/AS and CVB3/20 strains are only 85% identical in the region analyzed, the predicted RNA secondary structures were nearly identical ( figure 6, left and middle) . In contrast, the SLII of the noncardiovirulent CVB3/CO strain differed significantly in its predicted structure, compared with those of the cardiovirulent strains ( figure 6, right) . The optimal folding pattern of nt 88-186 of CVB3/CO predicted the formation of 3 separate SLs. Of interest, unlike the initial 17-nt single-stranded segment in cardiovirulent strains, which separates the cloverleaf domain from the putative SLII, some bases within nt 88-104 of CVB3/CO were involved in base-pair interactions. As a result, the predicted inter-SLI-II linker was significantly reduced in length (7 nt. vs. 17 nt).
To further validate the predicted folding pattern and to assess whether the cardiovirulence-determining region will alter the enterovirus cloverleaf structure, all CVB3 SLII regions were computationally folded in conjunction with the initial 87 nt of CVB3/20 (present in all of the chimeric strains described). The 5 terminal sequences formed the predicted enterovirus cloverleaf structure independently of the predicted folding patterns of nt 88-181 (data not shown). Furthermore, the cardiovirulence-determining sequences adopted the identical motif shown in figure 6 .
DISCUSSION
For the selected naturally occurring CVB3 strains, we have demonstrated that the primary molecular determinant of cardiovirulence phenotype is an RNA segment (94-99 nt in length) that constitutes the predicted SLII within the 5 NTR. Exchange of nt 88-181 in cardiovirulent CVB3 viruses (CVB3/20 or CVB3/ AS5 P1/20) by homologous sequences (nt 88-186) from the noncardiovirulent CVB3/CO clinical isolate resulted in amyocarditic progeny viruses. Conversely, when cardiovirulence-determining sequences derived from the cardiovirulent CVB3/20 and CVB3/ AS strains replaced the homologous region in an amyocarditic chimera (CVB3/CO5 P1/20), the intra-5 NTR recombinants were cardiovirulent for mice. Similar to this finding, exchange of sequences that constitute the ECV12 SLII with those of CVB3 reversed the attenuated phenotype of an echovirus-coxsackievirus chimera (ECV12[5 NTR]CVB3).
Only 1 mouse inoculated with CO-SLII/20 exhibited histological evidence of moderate inflammatory foci and of the presence of infectious virus, within the myocardium. The finding that a noncardiovirulent CVB3 strain can occasionally induce inflammatory heart disease in a murine model is not unusual or unprecedented. In a report concerning the noncardiovirulent CVB3/0 strain, 4 of 10 mice predicted to be disease free, on the basis of the presence of a nucleotide 234C mutation, were found to have minor myocardial lesions [30] . Sequence analyses of the viruses recovered from the myocardia revealed that a spontaneous mutation at nucleotide 234 (CrU) had occurred in vivo. Within the 5 NTR that included the SLII, direct sequencing of RT-PCR products generated from the cardiac-derived CO-SLII/20 failed to reveal mutations, compared with those from the inoculum sequence. It is possible that the observed cardiovirulence phenotype may have been the result of a downstream mutation or of the presence of a virus subspecies in the background of the noncardiovirulent genome that had gone undetected. In addition, murine-related factors-such as age, immune status, or general health status-might have affected susceptibility to CVB3 infection.
Of interest, a direct correlation was noted between in vivo virulence phenotype and cell type-specific in vitro replication fitness. The differential growth characteristics observed between myocarditic and attenuated CVB3 in cardiac-derived cells parallel those observed between neuroattenuated and neurovirulent poliovirus in cells of human neuronal origin [25] . Only the cardiovirulent CVB3 exhibited significant growth in MFHF at 37ЊC. In contrast, when viruses of either cardiovirulence phenotype were propagated in HeLa cells, a highly permissive cell line for CVB, no significant differences in growth characteristics were noted ( figure 4A and 4B) . Reducing the incubation temperature from 37ЊC to 33.5ЊC relieved the MFHF growth restriction of noncardiovirulent CVB3 chimeras, a finding that suggests a potential stabilization of the RNA-RNA and/ or RNA-protein interaction necessary for 5 NTR function in MFHF. These findings point to differences within the intracellular environments of MFHF and HeLa cells that affect susceptibility to enterovirus infection. Furthermore, they support other reports that indicate that the enterovirus 5 NTR contains nonreceptor determinants of tissue and/or species tropism [33, [40] [41] [42] . However, the abilities of noncardiovirulent CVB3/CO and chimeric constructs to replicate in other, non-cardiac murine tissues were not restricted. Tracy et al. [43] found that 7 of 8 clinical CVB3 strains, including CVB3/CO, replicated well in the murine pancreas and induced pancreatitis, regardless of cardiovirulence phenotype. Similar to this finding, the noncardiovirulent CVB3 chimeras in this and other studies [32] were found to be pancreovirulent in a murine model (unpublished data).
Our approach to identify the CVB3 determinant of cardiovirulence was to use clinical isolates. All currently available full-length infectious CVB3 cDNA clones that have been used in attempts to identify cardiovirulence determinants share extremely high nucleotide and amino acid identities. Furthermore, all clones appear to be derived from a common progenitor strain (Nancy) [44] [45] [46] , and all cluster within the same Nancy-like genogroup. The Nancy-like genotype no longer circulates in the United States (US), as determined by sequence analysis of 1100 clinical CVB3 isolates dating from 1956 to 1998 [46] (unpublished data). Thus, the commonly used laboratory strains appear to represent a viral clade that no longer circulates in the general US population. The clinical isolates used in this study exhibit significantly less nucleotide identity with the Nancy strain.
The findings reported here are in accord with data derived from analyses of poliovirus virulence. For all 3 poliovirus serotypes, major determinants of neuroattenuation reside within the SLV of the 5 NTR [47] . The single nucleotide changes (positions 480, 481, and 472, of types 1, 2, and 3 polioviruses, respectively) are believed to alter 5 NTR higher-order RNA structure, thereby interfering with the ability of SLV to interact with trans-acting factors required for tissue-specific (neuronal) internal initiation of translation [13, 22, 48] . As with poliovirus, a primary determinant of CVB3 cardiovirulence has been localized to the 5 NTR. However, the CVB3 virulence determinant is located ∼300 nt farther upstream, within sequences predicted to form the inter-SLI-SLII linker and SLII.
Because it is known that the enterovirus 5 NTR contains higher-order RNA structures required for both viral translation and viral replication, we predicted, by computation, the possible secondary structures contained within the CVB3 cardiovirulence determinant region, to examine their potential relationship with the respective cardiovirulence phenotypes. Despite the fact that the cardiovirulent CVB3/AS and CVB3/20 strains were 85% identical within this region (figure 1), their predicted SLII structures were strikingly similar. Of note is the significant dissimilarity of the latter structures, compared with those of the amyocarditic CVB3/CO SLII. Although the characteristics of these structures have not yet been examined biochemically, they may lend insight into the possible molecular mechanisms determining CVB3 cardiovirulence.
The predicted differences in the SLII RNA structure between noncardiovirulent and cardiovirulent strains may influence binding to the 5 NTRs of specific proteins required for efficient 5 NTR function in cardiac cells. For the neuroattenuated type 3 poliovirus 5 NTR, reduced binding of polypyrimidine tractbinding protein in neuroblastoma cells, but not in HeLa cells, was observed, compared with that of the wild-type 3 poliovirus 5 NTR [48] . Two cellular proteins that bind RNA sequences predicted to form the structurally similar type 1 poliovirus (Mahoney strain) SLII have been reported. The translation factor eIF-2a interacted with 2 noncontiguous regions comprising nt 97-182 and nt 510-629 [49] . Polypyrimidine tract-binding protein interacted with 3 noncontiguous type 1 poliovirus 5 NTR sites: nt 70-288, nt 443-539, and nt 630-730 [50] . Evidence suggests a dual role for upstream 5 NTR RNA sequences, which have traditionally been believed to be solely part of the internal ribosomal entry site. Mutations of elements within poliovirus SLII have been shown to influence both internal ribosomal entry site-dependent translation initiation [41, 42, 51] and plus-strand RNA synthesis [52, 53] . Thus, SLII identity may affect 1 or both of these processes.
Numerous reports have documented the effects of immune activation on the development of CVB3-induced murine myocarditis (reviewed in [54] ). For example, in vivo depletion of CD8 ϩ T lymphocytes from mice infected with a cardiovirulent strain of CVB3 resulted in reduced inflammatory heart disease [55] . In addition, genetically distinct murine strains exhibit differential susceptibilities to CVB3 heart disease [56] . Thus, although host immune and genetic components to CVB3 myocarditis exist, it is clear that strain-specific genotypic traits of wild-type CVB3 play a major role in development of the disease. Data presented here suggest that competence of CVB3 5 NTR function in cardiac cells may determine virulence phenotype, which, in turn, may be modulated by other host factors. In summary, we have used 2 phenotypically and genotypically distinct clinical CVB3 strains to localize the natural genetics of cardiovirulence to a single predicted SL structure in the 5 NTR. Although no full-length infectious cDNA copies of the amyocarditic CVB3/CO or myocarditic CVB3/AS clinical strains exist, experiments with the 5 half of these viral genomes have ruled out the idea that the P1 and downstream 5 NTR sequences are the primary contributors to cardiovirulence phenotype [32] . The data presented here unambiguously demonstrate the role that the sequences that constitute both the putative SLI-II linker and SLII play in determining cardiovirulence. However, it remains possible that, as with poliovirus, additional determinants of attenuation exist within the nonstructural protein coding regions of the CVB3 genome.
